Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533880 · ClinicalTrials.gov registry record · NA
The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT04533880 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 150 participants.
The verdict
NCT04533880, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
One of the common complaints after ACLR with BPTB autograft anterior knee pain. It is thought that this may be due to harvesting the patellar tendon for graft use. Specifically, this may be due to the bone defect that is left after graft harvesting. There is currently no consensus on a gold standard for treating the bone defect with surgeons using multiple commercially available bone void fillers as well as autologous bone graft in standard practice. The purpose of the proposed study is to evaluate the effect bone-void filler on anterior knee pain following ACL reconstruction BPTB autograft.
Interventions
- DEVICE DBM
- DEVICE Calcium phosphate cement
- OTHER Autologous bone graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2023-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04533880
The ClinicalTrials.gov registry entry for NCT04533880 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which DBM is the first listed.
NCT04533880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04533880 about?
NCT04533880 is a clinical study titled "The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction". One of the common complaints after ACLR with BPTB autograft anterior knee pain. It is thought that this may be due to harvesting the patellar tendon for graft use. Specifically, this may be due to the bone defect that is left after graft harvesting. There is currently no consensus on a gold standard...
What is the current status of trial NCT04533880?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2020-08-31. Estimated completion is 2023-07-07.
What interventions are being tested in trial NCT04533880?
The interventions under investigation include: DBM (DEVICE), Calcium phosphate cement (DEVICE), Autologous bone graft (OTHER).
Who is sponsoring clinical trial NCT04533880?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.